565 related articles for article (PubMed ID: 26770668)
1. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.
George L; Brightling CE
Ther Adv Chronic Dis; 2016 Jan; 7(1):34-51. PubMed ID: 26770668
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
4. [Eosinophilic chronic obstructive pulmonary disease: A review].
Anaev EK
Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
[TBL] [Abstract][Full Text] [Related]
5. Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
Moermans C; Damas K; Guiot J; Njock MS; Corhay JL; Henket M; Schleich F; Louis R
Cytokine; 2021 Apr; 140():155421. PubMed ID: 33486314
[TBL] [Abstract][Full Text] [Related]
6. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.
Hiles SA; Gibson PG; McDonald VM
Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971
[TBL] [Abstract][Full Text] [Related]
7. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic airway inflammation in COPD.
Saha S; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
[TBL] [Abstract][Full Text] [Related]
9. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.
Tashkin DP; Wechsler ME
Int J Chron Obstruct Pulmon Dis; 2018; 13():335-349. PubMed ID: 29403271
[TBL] [Abstract][Full Text] [Related]
10. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.
Hargreave FE; Leigh R
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S53-7. PubMed ID: 10556171
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic airway disorders.
Scott KA; Wardlaw AJ
Semin Respir Crit Care Med; 2006 Apr; 27(2):128-33. PubMed ID: 16612763
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
[TBL] [Abstract][Full Text] [Related]
13. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils in COPD-Current Concepts and Clinical Implications.
Mycroft K; Krenke R; Górska K
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
[TBL] [Abstract][Full Text] [Related]
15. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
[TBL] [Abstract][Full Text] [Related]
16. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
Kulkarni NS; Hollins F; Sutcliffe A; Saunders R; Shah S; Siddiqui S; Gupta S; Haldar P; Green R; Pavord I; Wardlaw A; Brightling CE
J Allergy Clin Immunol; 2010 Jul; 126(1):61-9.e3. PubMed ID: 20639010
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
Albertson TE; Chenoweth JA; Pearson SJ; Murin S
Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
[No Abstract] [Full Text] [Related]
19. Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease.
Yi X; Li Y; Liu H; Liu X; Yang J; Gao J; Yang Y; Liang Z; Wang F; Chen D; Wang L; Shi W; Lam DCL; Stampfli MR; Jones PW; Chen R; Wang Z
Microbiol Spectr; 2022 Apr; 10(2):e0259321. PubMed ID: 35311590
[TBL] [Abstract][Full Text] [Related]
20. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
